We found that the amount of soluble GAPDH and insoluble GAPDH complexes with Aβ in the CSF from patients with various stages of AD directly correlated with the severity of the disease; the increase was apparent at moderate and severe stages of AD, as classified by MMSE. Here, GAPDH is linked to Alzheimer disease.